Journal Article Summary
The article investigates the effects of GR 38032F, a medication that blocks 5-HT3 receptors and is known for its ability to prevent nausea caused by chemotherapy, on motion sickness and eye movement functions. Understanding how different medications affect motion sickness is important because it can help identify effective treatments for individuals who experience nausea during travel or other motion-related activities. This study aims to clarify whether GR 38032F can help prevent motion sickness, as well as to explore its impact on oculomotor functions, which are essential for coordinating eye movements.
In this study, researchers conducted a double-blind trial involving participants who received either GR 38032F, a placebo, or hyoscine, a known treatment for motion sickness. The results showed that GR 38032F did not significantly reduce motion-induced nausea compared to the placebo, while hyoscine demonstrated a notable improvement in tolerance to motion. Additionally, the study assessed eye movement functions and found that neither GR 38032F nor hyoscine affected saccadic eye movements, but both medications slightly reduced the speed of eye movements during tracking tasks.
The study has some limitations, including a small sample size and the specific focus on a single type of motion sickness. These factors may affect the generalizability of the findings. Patients should be aware that while GR 38032F is effective for nausea related to chemotherapy, it may not be suitable for motion sickness. It is advisable for individuals experiencing motion sickness to discuss treatment options with their healthcare provider, who can recommend appropriate therapies based on their specific needs and medical history.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Stott J R, Barnes G R, Wright R J, Ruddock C J. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.. British Journal of Clinical Pharmacology 1989. DOI: 10.1111/j.1365-2125.1989.tb05345.x. PMID: 2523720. PMCID: PMC1379774.
Featured Pill Pals Product
Ondansetron 4 mg Tablets --- Generic For Zofran --- Rising Pharma
Ondansetron 4 mg Tablets — Generic For Zofran — Rising Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
